Physician profile
Ethan Rutledge
NPI 1508156696
$15,288.58
in general payments reported to CMS, 2019-2025
53 companies · $3,009 in 2025
The $3,009 reported for 2025 was more than what 83% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,117 · 2020: $1,312 · 2021: $1,728 · 2022: $2,039 · 2023: $2,363 · 2024: $2,722 · 2025: $3,009.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,955 · Education: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,955.31 |
| Education | $138.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,385.20 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,814.50 | 2019-2025 | Airsupra, Tezspire, Breztri |
| Actelion Pharmaceuticals US, INC. | $1,607.28 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Grifols USA, LLC | $1,386.65 | 2019-2025 | Prolastin-C Liquid |
| Insmed, INC. | $792.27 | 2022-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $609.09 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| United Therapeutics Corporation | $564.97 | 2021-2025 | Tyvaso, Tyvaso |
| Genzyme Corporation | $555.66 | 2020-2025 | |
| Sunovion Pharmaceuticals INC. | $538.82 | 2019-2021 | |
| Baxter Healthcare | $480.67 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Mylan Specialty L.P. | $393.46 | 2019-2024 | Yupelri |
| Jazz Pharmaceuticals INC. | $372.38 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $322.03 | 2021-2025 | Dupixent |
| Verona Pharma, INC. | $308.06 | 2025 | Ohtuvayre |
| Inspire Medical Systems, INC. | $279.84 | 2023-2025 | Inspire |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $244.85 | 2022-2025 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $238.04 | 2022-2025 | Glassia |
| Astellas Pharma US INC | $219.00 | 2019-2021 | |
| Pfizer INC. | $195.49 | 2022-2024 | |
| Axsome Therapeutics, INC. | $171.37 | 2023-2024 | Sunosi |
| Merck Sharp & Dohme LLC | $170.66 | 2019-2025 | Winrevair, Zerbaxa, Keytruda |
| Viatris Specialty LLC | $149.29 | 2025 | Yupelri |
| Mallinckrodt Hospital Products INC. | $146.37 | 2022-2025 | Acthar |
| Harmony Biosciences LLC | $136.50 | 2022-2025 | Wakix |
| Genentech USA, INC. | $133.98 | 2019-2020 | |
| La Jolla Pharmaceutical Company | $102.64 | 2024-2025 | Xacduro, Giapreza |
| Sanofi-Aventis U.S. LLC | $99.95 | 2025 | |
| Advanced Respiratory, INC | $72.35 | 2019-2020 | |
| Philips North America LLC | $61.86 | 2019-2022 | |
| Lilly USA, LLC | $56.60 | 2025 | Zepbound, Mounjaro |
| Pulmonx Corporation | $54.24 | 2022-2023 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Inogen, INC. | $53.23 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Resmed Corp | $47.95 | 2023 | |
| Janssen Pharmaceuticals, INC | $46.82 | 2021-2023 | |
| Circassia INC. | $43.21 | 2019 | |
| Idorsia Pharmaceuticals US INC | $34.01 | 2023 | Quviviq |
| Breas Medical, INC. | $34.01 | 2025 | Vivo 45 Ls |
| Fisher & Paykel Healthcare INC | $33.18 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $30.30 | 2019-2022 | |
| Caris Mpi, INC. | $29.20 | 2025 | Mi Cancer Seek |
| Allergan, INC. | $29.16 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $28.83 | 2023 | Nuzyra |
| Arbor Pharmaceuticals, INC. | $28.49 | 2019 | |
| Vifor Pharma, INC. | $24.57 | 2024 | Zemaira |
| Gilead Sciences, INC. | $21.81 | 2022 | |
| Portola Pharmaceuticals, LLC | $20.51 | 2019 | |
| Zoll Respicardia, INC. | $20.24 | 2022 | |
| Mallinckrodt Enterprises LLC | $19.24 | 2019 | |
| Abbvie INC. | $18.86 | 2022 | |
| Ambu INC. | $17.37 | 2023 | |
| Amgen INC. | $16.34 | 2025 | Tavneos |
| Teva Pharmaceuticals USA, INC. | $14.91 | 2021 | |
| Biogen, INC. | $12.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Rutledge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.